Nuwellis Inc Net Assets
Nuwellis Inc net assets. Based on the latest financial reports, Nuwellis Inc (NUWE) has net assets worth $-2.04 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($9.13 Million) and total liabilities ($11.17 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore NUWE net assets growth trend to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-2.04 Million |
| % of Total Assets | -22.41% |
| Annual Growth Rate | 3.77% |
| 5-Year Change | -89.86% |
| 10-Year Change | 49.69% |
| Growth Volatility | 1057.96 |
Net Assets of Nuwellis Inc (2002–2025)
Net assets of Nuwellis Inc from 2002 to 2025. This chart illustrates how Nuwellis Inc's net assets have evolved over time, based on quarterly financial data. See Nuwellis Inc balance sheet quality to measure how much of total assets are equity-financed.
Annual Net Assets for Nuwellis Inc (2002–2025)
The table below shows the annual net assets of Nuwellis Inc from 2002 to 2025. For live market cap and overall valuation, see Nuwellis Inc stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $2.63 Million | -59.72% |
| 2024-12-31 | $6.53 Million | +103.36% |
| 2023-12-31 | $3.21 Million | -74.01% |
| 2022-12-31 | $12.36 Million | -52.38% |
| 2021-12-31 | $25.95 Million | +59.01% |
| 2020-12-31 | $16.32 Million | +720.00% |
| 2019-12-31 | $1.99 Million | -66.48% |
| 2018-12-31 | $5.94 Million | -63.44% |
| 2017-12-31 | $16.24 Million | +824.19% |
| 2016-12-31 | $1.76 Million | -85.56% |
| 2015-12-31 | $12.17 Million | -58.34% |
| 2014-12-31 | $29.21 Million | -43.52% |
| 2013-12-31 | $51.73 Million | +299.47% |
| 2012-12-31 | $12.95 Million | +181.74% |
| 2011-12-31 | $4.60 Million | +14.40% |
| 2010-12-31 | $4.02 Million | 0.00% |
| 2009-12-31 | $4.02 Million | +145.36% |
| 2008-12-31 | $1.64 Million | -82.77% |
| 2007-12-31 | $9.51 Million | +37.95% |
| 2006-12-31 | $6.89 Million | +57.18% |
| 2005-12-31 | $4.38 Million | -39.97% |
| 2004-12-31 | $7.30 Million | +5136.46% |
| 2003-12-31 | $139.47K | -87.57% |
| 2002-12-31 | $1.12 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nuwellis Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 31427274778.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Nuwellis Inc Net Assets Breakdown (December 2025)
Nuwellis Inc net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Other Comprehensive Income | $8.00K | 0.30% |
| Other Components | $318.93 Million | 12154.27% |
| Total Equity | $2.62 Million | 100.00% |
Nuwellis Inc Competitors by Market Cap
The table below lists competitors of Nuwellis Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SIGNATURE RESOURCES NEW
F:3S30
|
$2.46 Million |
|
Global Power Solutions Corp.
V:PWER
|
$2.46 Million |
|
NuGen Medical Devices Inc
V:NGMD
|
$2.46 Million |
|
Imagine Lithium Inc
V:ILI
|
$2.46 Million |
|
Aptevo Therapeutics Inc
NASDAQ:APVO
|
$2.46 Million |
|
Lanesborough Real Estate Investment Trust
V:LRT-UN
|
$2.46 Million |
|
ROUTE1 INC.
F:3R6N
|
$2.46 Million |
|
Nexera Energy Inc
V:NGY
|
$2.46 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nuwellis Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 6,530,000 to 2,624,000, a change of -3,906,000 (-59.8%).
- Net loss of 17,521,000 reduced equity.
- New share issuances of 6,940,000 increased equity.
- Other comprehensive income increased equity by 55,000.
- Other factors increased equity by 6,620,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-17.52 Million | -667.72% |
| Share Issuances | $6.94 Million | +264.48% |
| Other Comprehensive Income | $55.00K | +2.1% |
| Other Changes | $6.62 Million | +252.29% |
| Total Change | $- | -59.82% |
Book Value vs Market Value Analysis
This analysis compares Nuwellis Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.44x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.00x to 0.44x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | $56113700.00 | $5.91 | x |
| 2003-12-31 | $6973450.00 | $5.91 | x |
| 2004-12-31 | $365161750.00 | $5.91 | x |
| 2005-12-31 | $219191450.00 | $5.91 | x |
| 2006-12-31 | $344518550.00 | $5.91 | x |
| 2007-12-31 | $475258650.00 | $5.91 | x |
| 2008-12-31 | $81869200.00 | $5.91 | x |
| 2009-12-31 | $200872950.00 | $5.91 | x |
| 2010-12-31 | $200872950.00 | $5.91 | x |
| 2011-12-31 | $229800000.00 | $5.91 | x |
| 2012-12-31 | $647450000.00 | $5.91 | x |
| 2013-12-31 | $1034540000.00 | $5.91 | x |
| 2014-12-31 | $584300000.00 | $5.91 | x |
| 2015-12-31 | $243420000.00 | $5.91 | x |
| 2016-12-31 | $25100000.00 | $5.91 | x |
| 2017-12-31 | $231971428.57 | $5.91 | x |
| 2018-12-31 | $59360000.00 | $5.91 | x |
| 2019-12-31 | $1895238.10 | $5.91 | x |
| 2020-12-31 | $877311.83 | $5.91 | x |
| 2021-12-31 | $556802.58 | $5.91 | x |
| 2022-12-31 | $104401.82 | $5.91 | x |
| 2023-12-31 | $2402.89 | $5.91 | x |
| 2024-12-31 | $206.64 | $5.91 | x |
| 2025-12-31 | $13.31 | $5.91 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nuwellis Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -667.72%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -211.86%
- • Asset Turnover: 1.35x
- • Equity Multiplier: 2.33x
- Recent ROE (-667.72%) is below the historical average (-285.13%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | -726.59% | -4324.88% | 0.02x | 10.11x | $-1.03 Million |
| 2004 | -52.26% | -999.77% | 0.05x | 1.05x | $-4.55 Million |
| 2005 | -119.09% | -416.61% | 0.26x | 1.08x | $-5.66 Million |
| 2006 | -142.05% | -358.29% | 0.38x | 1.03x | $-10.48 Million |
| 2007 | -98.02% | -2207.60% | 0.04x | 1.02x | $-10.27 Million |
| 2008 | -398.21% | -6020.39% | 0.05x | 1.21x | $-6.68 Million |
| 2009 | -138.20% | -1387.90% | 0.09x | 1.11x | $-5.95 Million |
| 2010 | -138.20% | -1387.90% | 0.09x | 1.11x | $-5.95 Million |
| 2011 | -352.39% | 0.00% | 0.00x | 1.62x | $-16.66 Million |
| 2012 | -108.62% | 0.00% | 0.00x | 1.16x | $-15.36 Million |
| 2013 | -42.06% | -36877.97% | 0.00x | 1.07x | $-26.93 Million |
| 2014 | -87.58% | -8673.56% | 0.01x | 1.11x | $-28.51 Million |
| 2015 | -218.41% | -45055.93% | 0.00x | 2.02x | $-27.80 Million |
| 2016 | -898.80% | -1225.14% | 0.17x | 4.25x | $-15.97 Million |
| 2017 | -82.41% | -376.64% | 0.19x | 1.14x | $-15.01 Million |
| 2018 | -286.93% | -340.78% | 0.57x | 1.48x | $-17.63 Million |
| 2019 | -910.25% | -328.69% | 0.98x | 2.82x | $-18.31 Million |
| 2020 | -97.05% | -212.82% | 0.37x | 1.23x | $-17.47 Million |
| 2021 | -75.36% | -246.86% | 0.26x | 1.17x | $-22.15 Million |
| 2022 | -117.54% | -170.02% | 0.35x | 2.00x | $-15.76 Million |
| 2023 | -629.37% | -227.99% | 0.91x | 3.04x | $-20.53 Million |
| 2024 | -170.98% | -127.75% | 0.89x | 1.51x | $-11.82 Million |
| 2025 | -667.72% | -211.86% | 1.35x | 2.33x | $-17.78 Million |
Industry Comparison
This section compares Nuwellis Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $296,528,539
- Average return on equity (ROE) among peers: -35.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nuwellis Inc (NUWE) | $-2.04 Million | -726.59% | N/A | $2.46 Million |
| Abbott Laboratories (ABT) | $2.83 Billion | 34.08% | 0.96x | $190.23 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-95.88 Million | 0.00% | 0.00x | $2.34 Million |
| Aethlon Medical Inc (AEMD) | $-3.66 Million | 0.00% | 0.00x | $1.11 Million |
| Acutus Medical Inc (AFIB) | $-11.59 Million | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $850.46 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $9.37 Million | 23.33% | 0.30x | $2.43 Million |
| Allurion Technologies, Inc. (ALUR) | $-77.98 Million | 0.00% | 0.00x | $21.01K |
| Autonomix Medical, Inc. Common Stock (AMIX) | $5.89 Million | -283.55% | 0.29x | $1.61 Million |
| Artivion Inc (AORT) | $276.20 Million | -4.84% | 1.86x | $1.03 Billion |
| Apyx Medical Inc (APYX) | $14.18 Million | 18.92% | 0.18x | $109.52 Million |
About Nuwellis Inc
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly… Read more